We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHIXW
151
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$38.3K ﹤0.01%
166,664
MPRAW
152
DELISTED
Mercato Partners Acquisition Corporation Warrant
MPRAW
$36.6K ﹤0.01%
375,000
SEPAW
153
DELISTED
SEP Acquisition Corp Warrants
SEPAW
$34.8K ﹤0.01%
866,250
FMIVW
154
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$31.3K ﹤0.01%
250,000
RCFA.WS
155
DELISTED
RCF Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
RCFA.WS
$29.5K ﹤0.01%
300,000
EQRXW
156
DELISTED
EQRx, Inc. Warrant
EQRXW
$25.4K ﹤0.01%
139,825
-10,175
-7% -$2.7K
CVIIW
157
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$24.5K ﹤0.01%
200,000
LCAHW
158
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$23.4K ﹤0.01%
125,000
JWSM.WS
159
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$21.7K ﹤0.01%
200,000
MVLAW
160
DELISTED
Movella Holdings Inc. Warrant
MVLAW
$21.7K ﹤0.01%
150,000
SLACW
161
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$21.3K ﹤0.01%
187,500
TBCPW
162
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$18K ﹤0.01%
150,000
BCSAW
163
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$17.3K ﹤0.01%
150,000
APGB.WS
164
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$14.6K ﹤0.01%
150,000
CITEW
165
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$14.2K ﹤0.01%
175,000
IPVIW
166
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$13.1K ﹤0.01%
120,000
SPCMW
167
DELISTED
Sound Point Acquisition Corp I, Ltd Warrant
SPCMW
$12.2K ﹤0.01%
150,000
BWCAW
168
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
$12K ﹤0.01%
143,750
CCVI.WS
169
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$8.8K ﹤0.01%
80,000
LGVCW
170
DELISTED
LAMF Global Ventures Corp. I Warrant
LGVCW
$6.41K ﹤0.01%
200,000
FSRXW
171
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$6.33K ﹤0.01%
150,000
VMGAW
172
DELISTED
VMG Consumer Acquisition Corp. Warrant
VMGAW
$4.13K ﹤0.01%
175,000
SLAMW
173
DELISTED
Slam Corp. warrant
SLAMW
$4.05K ﹤0.01%
17,627
GETR.WS
174
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$3.76K ﹤0.01%
80,000
AEON.WS
175
DELISTED
AEON Biopharma Inc
AEON.WS
$2.75K ﹤0.01%
49,995

Similar funds

Thomas Steyer's Q1 2023 Portfolio in Review

As of Q1 2023, Thomas Steyer held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Thomas Steyer withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in UnitedHealth worth $409M.

  • Thomas Steyer's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Thomas Steyer's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Thomas Steyer fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Thomas Steyer's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Thomas Steyer opened 14 new positions and closed 63 in Q1 2023.
  • Thomas Steyer's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.